Neuroblastoma associated with pyrexia of unknown origin: An unusual presentation

Neuroblastoma is the most common extracranial solid malignancy in children and may present with diverse clinical features. We report a case of a 4-month-old male infant who presented with pyrexia of unknown origin (PUO) and was found to have a retroperitoneal mass (84×74×88 mm) on imaging. Histopathological and immune-histochemical findings confirmed the diagnosis of neuroblastoma. The tumor was staged as 1/2A as per the International Neuroblastoma Risk Group Staging System (INRGSS), as per guideline close observation and follow up initiated. After that this case classified under intermediate risk disease and start neoadjuvant chemotherapy for 6 to 24 week. This case highlights the importance of considering neuroblastoma in the differential diagnosis of PUO in infants, even under 6 months of age.

Authors

Publication Details

Journal
International Journal of Pediatrics and Neonatology
Published
2025-01-01
DOI
https://doi.org/10.33545/26648350.2025.v7.i2a.143
Primary Topic
Hematological disorders and diagnostics
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neuroblastoma associated with pyrexia of unknown origin: An unusual presentation

Prasun Bhattacharjee, Pranay Trivedi, Ashwani Parashar, Patoliya Jay Jagdishbhai
International Journal of Pediatrics and Neonatology
Hematological disorders and diagnostics
article

Neuroblastoma associated with pyrexia of unknown origin: An unusual presentation

Prasun Bhattacharjee, Pranay Trivedi, Ashwani Parashar, Patoliya Jay Jagdishbhai
article en

Abstract

Neuroblastoma is the most common extracranial solid malignancy in children and may present with diverse clinical features. We report a case of a 4-month-old male infant who presented with pyrexia of unknown origin (PUO) and was found to have a retroperitoneal mass (84×74×88 mm) on imaging. Histopathological and immune-histochemical findings confirmed the diagnosis of neuroblastoma. The tumor was staged as 1/2A as per the International Neuroblastoma Risk Group Staging System (INRGSS), as per guideline close observation and follow up initiated. After that this case classified under intermediate risk disease and start neoadjuvant chemotherapy for 6 to 24 week. This case highlights the importance of considering neuroblastoma in the differential diagnosis of PUO in infants, even under 6 months of age.

International Journal of Pediatrics and NeonatologyVol. 7(2)
Openalex Percentile: Top 68%
Hematological disorders and diagnostics
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.